Skip to main content

Would You Like Marijuana with Your Chemotherapy?


I am frequently asked, as a pharmacist who specialises in cancer medicine, what do I think about the use of marijuana for medical conditions?

I often reflect back to dispensing dronabinol (a synthetic THC product) for chemotherapy induced nausea and HIV related wasting syndrome, when I first started working as a pharmacist in a hospital in the early 90s.  Back then it was no big deal, the hospital pharmacy imported the medication from overseas, just like we did many other medications which were not marketed in Australia, and supplied it on a doctor’s prescription.

We didn’t stop supplying it because it was difficult to get hold of, rather it just wasn’t very useful any more.  New anti-nausea medications came on the market, and these were much more effective at controlling the nausea and vomiting associated with chemotherapy, and, a new class of medications known as antiretrovirals became available and these were so effective at treating HIV we thankfully were no longer seeing the devastating effects of the disease.

So, as the current debate over the use of marijuana for medical conditions rages and health professional seem pitted against consumers with politicians waging in (mostly unhelpfully) on the subject, what are the issues?  Notwithstanding the difficulties in completing all the paperwork and processes necessary to prescribe marijuana, the problems, as I see it, are as follows:
  • Firstly, and unfortunately, the debate over the use of marijuana is often hijacked by “conspiracy theorists”.  Those who think that big pharma has the cure for cancer and is just not telling us, and that we just get a kick out of poisoning people with cancer drugs because it keeps us in business.  These people will frequently make claims that marijuana cures cancer.  It is at this stage I like to point out that cancer is not one disease, it is hundreds of different diseases, with a couple of hundred different treatment options, and we DO, in fact, cure a number of cancers already.  Just ask ex-Australian cricketer, Simon O’Donnell, musician, Delta Goodrem and even the disgraced cyclist, Lance Armstrong.
  • Secondly, well-meaning patients (and patient advocates) will stand up and say how effective marijuana has been at treating their condition, without acknowledging the fact that they have also used or are currently still on conventional medication. This does not mean the marijuana they are using is not having a therapeutic effect, but it does make health professionals sceptical of such claims.
  • Thirdly, health professionals just don’t know how to use it properly, YET.  Health professionals are science nerds.  When giving a medication, they want to understand what diseases or symptoms it is useful in treating, what the medication does and what the effective dose is.  Much of this information is unclear at present.
  • Fourthly, and particularly in the absence of above, health professionals take comfort in discussing unfamiliar issues with a colleague who has experience in the area.  This is not specific to marijuana, they do it for most things – uncommon conditions, new medications, or a new kind of diagnostic test.  A chat with a colleague is one of the most common forms of informal learning.  Unfortunately, there are very few health professionals with experience in the use of marijuana to chat to.
  • Lastly, and rather disappointingly I think, some of the people providing educational offerings on the use of marijuana do not focus on points three and four, instead they discuss how safe it is compared to say alcohol, or they use terms in their presentations like “flying high”.  It is not helpful to refer to, or play up, recreational substance use – be that marijuana, alcohol or even nicotine in the argument for using marijuana for medical conditions. Being less harmful, does not make it effective.


So, does that mean I don’t think marijuana is useful?

No. I DO think it will have a place in therapy. 

Based on what we know at present it may be useful as a mild to moderate pain reliever (when used in combination with other medications), there is also some early pre-clinical data on its use in combination with chemotherapy in cancer, though pre-clinical data does not mean it will work clinically in patients.  But by far the most interesting research and the greatest hope is on its use in neurological conditions.  Data on reducing the frequency of seizures in refractory epilepsy is compelling and improvements in spasticity in multiple sclerosis are promising.

My hope is that we can address the gaps in health professional’s education so that we increase their confidence in using marijuana appropriately, so that those who may benefit from its use, can do so. chemo@home is committed to helping both consumers and health professionals find the information they need.  Our website now has relevant information on access, supply and evidence on use, which we will continue to add to.  There is also a form for health professionals to upload case studies on the use of marijuana in their patients, so we can all learn from the experience.  If you have feed-back on what you want included or ways to improve the information provided, please leave a comment.

Addit:  You will notice I have not used the popular term, medicinal marijuana. Since we do not say medicinal penicillin or medicinal codeine, I do not think it is necessary here either.  I have also used the term marijuana for simplicity, and not the more “pharmaceutically correct” terms cannabinoids, cannabidiol (CBD) or tetrahydrocannabinol (THC).

Julie

Comments

Popular posts from this blog

Go Fund Me – I Don’t Want Chemo

As a woman I have breasts.  As a white, western, woman I have about a 1 in 8 chance of getting breast cancer.If I get breast cancer, I really don’t want chemotherapy, if I can avoid it.Not unless it will make a significant difference to my outcome. Until recently, knowing if this was the case, was difficult.
Rarely does a study comes out and say that chemotherapy is not needed; that it does not reduce the likelihood of the cancer coming back and does not increase survival.
But that is exactly what has happened in a large trial on breast cancer patients with hormone-receptor–positive, human epidermal growth factor receptor 2 (HER2)–negative, axillary node–negative breast cancer, who would have until now, been given what is known as adjuvant chemotherapy.
Adjuvant chemotherapy is chemotherapy which is given after a potentially curative procedure (in the case of breast cancer this is surgery) to mop up any remaining cancer cells in the body that we can’t see. It’s a tricky business.  We’ve …

When exercise really is the best medicine

In 1997 a study was published in “Blood”, arguably the most respected medical journal on blood cancers on planet earth.The study was about the effect of exercise on treatment related fatigue after a type of bone marrow transplant called a peripheral blood stem cell transplant.The study peaked my interest, not just because of the positive benefits of exercise on reducing fatigue, but because it also showed a benefit in other somewhat more unexpected areas.It also reduced the length of time a patient’s white blood cell count is low after transplant, the severity of diarrhoea and the severity of pain.Of these the one that interested me most at the time, was the effect on the white blood cell count.The white cells are the part of your blood system which fight infection; without them the body is more prone to getting nasty bugs and less able to fight them off.
So, what was so interesting about this finding?In the early 80’s a medication, granulocyte-colony stimulating factor (G-CSF), which …